American International Group, Inc. Dice Therapeutics, Inc. Transaction History

American International Group, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 04, 2023	BUY	$25.86 - $46.71 $40,496 - $73,147	1,566 Added 9.17%	18,647 $866,000
Q1 2023 May 12, 2023	BUY	$26.05 - $32.31 $8,830 - $10,953	339 Added 2.02%	17,081 $489,000
Q4 2022 Feb 10, 2023	BUY	$19.77 - $42.23 $64,509 - $137,796	3,263 Added 24.21%	16,742 $522,000
Q3 2022 Nov 14, 2022	BUY	$14.97 - $22.65 $2,844 - $4,303	190 Added 1.43%	13,479 $273,000
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $84,073 - $140,865	6,374 Added 92.18%	13,289 $206,000
Q1 2022 May 13, 2022	SELL	$14.54 - $25.02 $7,066 - $12,159	-486 Reduced 6.57%	6,915 $132,000
Q4 2021 Feb 11, 2022	BUY	$22.41 - $37.54 $165,856 - $277,833	7,401 New	7,401 $187,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.